ceph

The transaction is expected to be completed in Q3 of 2011.

Shlomo Yanai, President and Chief Executive Officer of Teva said, "We are embarking today on a new and exciting future for Teva's branded business, and we are delighted that we will be working together with the Cephalon team.

Teva Pharmaceuticals (NASDAQ:TEVA) and Cephalon (NASDAQ:CEPH) announced that their boards of directors unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50

Good Morning. It's Friday, April 8, 2011. At this hour, U.S. equity futures are higher. Overseas, the Asian markets advanced, while the European markets are up. Rio Tinto (RIO) said it acquired a majority interest in Riversdale

Cephalon (CEPH) announced its board formally rejected Valeant Pharmaceuticals International, Inc.'s March 29 unsolicited proposal to purchase the company for $73 per share. Shares of Cephalon are down over 1% to $76.50 in pre-mark

Good Morning. It's Wednesday, April 6, 2011. At this hour, U.S. equity futures are up. Overseas, the Asian markets were mixed, while the European markets are higher.

The bank sees some upside to the $73 offer, but not much. Valeant could increase its offer marginally, and there is a reasonable possibility of an additional suitor coming along with a higher bid.

Shares of Cephalon are trading down 0.19% at $75.30.

UBS downgraded Cephalon (NASDAQ:CEPH) to neutral from buy, while raising its target price to $78, after a $73 per share buyout offer from Valeant was made public.

This is what's in the news for Thursday, March 31st. the Wall Street Journal reports that Berkshire Hathaway's (BRK.A) David Sokol has resigned over his personal stock trading...

JMP Securities also downgraded Cephalon (CEPH) to Market Perform from Outperform. The firm cited the acquisition proposal by Valeant (VRX), which the firm views as attractive and thinks shareholders will ultimately accept an offer

Meanwhile, Citigroup downgraded Gannett (GCI) to Hold from Buy.

JMP Securities has reportedly downgraded Rural/Metro (RURL) to Market Perform from Outperform. The firm cited the company's acquisition by Warburg Pincus as its reason. Shares closed at $17.04.

Equity futures are pointing higher this morning with the Dow Jones Industrial Average looking to open 44 points higher while the broader S&P500 is looking to open 6 points higher. Moving fast in the pre-market session are shar

The stock surged in after-hours trading Tuesday after Valeant Pharmaceuticals (VRX) said it made a proposal to the Board of Directors to acquire Cephalon for $73.00 per share in cash. The proposal, valued at approximately $5.7 bil

Shares of Valenant are up some 18% to $52.50 in pre-market action.

Cephalon (CEPH) is up 31% in pre-market trade, continuing the climb started last night on news of an acquisition offer. Shares are currently trading at $77.24

Good Morning. It's Wednesday, March 30, 2011. At this hour, U.S. equity futures are higher. Overseas, the Asian markets advanced, while the European markets are up.